You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 67, 20 June 2008
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary is posted shortly after the CMEC meeting to give quick notification of certain recommendations made by CMEC to the TGA. The TGA is yet to consider these recommendations and so this summary does not represent final decisions of TGA and should not be taken as such.
Reasons underlying these recommendations will be available after ratification of the Minutes at the next CMEC meeting. Other recommendations may be made at CMEC meetings but, because they concern confidential matters, or matters requiring further consideration by the TGA, they are not available for public disclosure.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 66, 18 April 2008), as amended, are a true and accurate record of that meeting.
CMEC recommends to the TGA that only the stir-fried burs of Xanthium sibiricum and Xanthium strumarium, prepared according to the monograph for 'Fructus Xanthii (stir-baked)' in the Pharmacopoeia of the People's Republic of China (2005), are suitable for use as an active ingredient in Listed medicines, at a maximum recommended daily dose of 9 g.
Members considered the report of the Vitamin E and Beta-carotene Expert Advisory Group.
CMEC recommends to the TGA that only preparations of the rhizome of Ligusticum wallichii are suitable for use as an ingredient in Listed medicines.
CMEC recommends to the TGA that only preparations of the root and rhizome of Ligusticum sinense are suitable for use as an ingredient in Listed medicines.
|Complementary Medicines Evaluation Committee meeting 67 (pdf)||105KB|